Drug profile · INN
prasterone
INTRAROSA
prasterone (INTRAROSA) is a unknown. Route of administration: vaginal. Current US regulatory status: approved.
FDA: approved EMA: approved Genito-urinary system and sex hormones (G03) G03XX01
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — prasterone
- US status
- approved
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- VAGINAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
prasterone (INTRAROSA) is a unknown. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
INN prasterone
Brand INTRAROSA
Mechanism Unknown
Therapeutic class Genito-urinary system and sex hormones (G03)
Route VAGINAL
Formulation INSERT
ATC code G03XX01
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prasterone?
prasterone (INTRAROSA) is a unknown. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for prasterone?
INTRAROSA is a marketed brand name for prasterone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prasterone?
prasterone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.